| Date Filed | Type | Description |
| 06/24/2022 |
4
| Canute Scott A (Director) has filed a Form 4 on Oncorus, Inc.|
Txns:
| Granted 12,500 options to buy
@ $1.6, valued at
$20k
|
|
| 11/19/2021 |
4
| Canute Scott A (Director) has filed a Form 4 on Flexion Therapeutics Inc|
Txns:
| Disposed/sold 9,000 shares
@ $8.5, valued at
$76.5k
Disposed/sold 18,000 options to buy
@ $25.38, valued at
$456.8k
Disposed/sold 9,000 options to buy
@ $21.85, valued at
$196.7k
Disposed/sold 12,500 options to buy
@ $13.83, valued at
$172.9k
Disposed/sold 12,500 options to buy
@ $20.16, valued at
$252k
Disposed/sold 12,500 options to buy
@ $28.14, valued at
$351.8k
Disposed/sold 12,500 options to buy
@ $11.74, valued at
$146.8k
Disposed/sold 7,000 options to buy
@ $11.88, valued at
$83.2k
Disposed/sold 7,000 options to buy
@ $9.22, valued at
$64.5k
|
|
| 06/28/2021 |
4
| Canute Scott A (Director) has filed a Form 4 on Flexion Therapeutics Inc|
Txns:
| Granted 4,500 shares
@ $0
Granted 7,000 options to buy
@ $9.22, valued at
$64.5k
|
|
| 06/17/2021 |
4
| Canute Scott A (Director) has filed a Form 4 on Oncorus, Inc.|
Txns:
| Granted 12,500 options to buy
@ $16.55, valued at
$206.9k
|
|
| 06/17/2021 |
4/A
| Canute Scott A (Director) has filed a Form 4 on Oncorus, Inc.|
Txns:
| Granted 25,000 options to buy
@ $26, valued at
$650k
|
|
| 12/16/2020 |
4
| Canute Scott A (Director) has filed a Form 4 on Oncorus, Inc.|
Txns:
| Granted 25,000 options to buy
@ $26, valued at
$650k
|
|
| 12/16/2020 |
3
| Canute Scott A (Director) has filed a Form 3 on Oncorus, Inc. |
| 10/23/2020 |
4
| Canute Scott A (Director) has filed a Form 4 on IMMUNOMEDICS INC|
Txns:
| Disposed/sold 13,516 shares
@ $0
Disposed/sold 155,286 options to buy
@ $0
Disposed/sold 3,718 restricted stock units
@ $0 |
|
| 06/22/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/12/2020 |
4
| Canute Scott A (Director) has filed a Form 4 on Flexion Therapeutics Inc|
Txns:
| Granted 4,500 shares
@ $0
Granted 7,000 options to buy
@ $11.88, valued at
$83.2k
|
|
| 06/21/2019 |
4
| Canute Scott A (Director) has filed a Form 4 on Flexion Therapeutics Inc|
Txns:
| Granted 12,500 options to buy
@ $11.74, valued at
$146.8k
|
|
| 06/11/2019 |
4
| Canute Scott A (Director) has filed a Form 4 on IMMUNOMEDICS INC|
Txns:
| Granted 9,667 shares
@ $0
Granted 17,077 options to buy
@ $12.93, valued at
$220.8k
|
|
| 06/10/2019 |
4
| Canute Scott A (Director) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Granted 13,700 shares
@ $0
Granted 20,100 options to buy
@ $4.23, valued at
$85k
|
|
| 03/11/2019 |
4
| Canute Scott A (Director) has filed a Form 4 on IMMUNOMEDICS INC|
Txns:
| Granted 79,818 options to buy
@ $16.96, valued at
$1.4M
Granted 22,854 options to buy
@ $16.35, valued at
$373.7k
|
|
| 09/18/2018 |
4
| Canute Scott A (Director) has filed a Form 4 on IMMUNOMEDICS INC|
Txns:
| Granted 3,849 shares
@ $0
Granted 6,497 options to buy
@ $14.29, valued at
$92.8k
|
|
| 06/21/2018 |
4
| Canute Scott A (Director) has filed a Form 4 on Flexion Therapeutics Inc|
Txns:
| Granted 12,500 options to buy
@ $28.14, valued at
$351.8k
|
|
| 06/15/2018 |
4
| Canute Scott A (Director) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Granted 12,500 options to buy
@ $11.14, valued at
$139.3k
|
|
| 06/11/2018 |
4
| Canute Scott A (Director) has filed a Form 4 on PROTEON THERAPEUTICS INC|
Txns:
| Granted 12,700 options to buy
@ $2.5, valued at
$31.8k
|
|
| 10/30/2017 |
4
| Canute Scott A (Director) has filed a Form 4 on Oncobiologics, Inc.|
Txns:
| Granted 15,000 options to buy
@ $1.32, valued at
$19.8k
|
|
| 07/27/2017 |
4
| Canute Scott A (Director) has filed a Form 4 on Flexion Therapeutics Inc|
Txns:
| Granted 12,500 options to buy
@ $20.16, valued at
$252k
|
|
| 07/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/21/2017 |
4
| Canute Scott A (Director) has filed a Form 4 on PROTEON THERAPEUTICS INC|
Txns:
| Granted 6,666 options to buy
@ $1.3, valued at
$8.7k
|
|
| 06/19/2017 |
4
| Canute Scott A (Director) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Granted 12,500 options to buy
@ $14.37, valued at
$179.6k
|
|
| 03/23/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 12/27/2016 |
4
| Canute Scott A (Director) has filed a Form 4 on Oncobiologics, Inc. |
| 11/30/2016 |
4
| Canute Scott A (Director) has filed a Form 4 on Oncobiologics, Inc. |
| 11/14/2016 |
4
| Canute Scott A (Director) has filed a Form 4 on Oncobiologics, Inc. |
| 08/02/2016 |
3
| Canute Scott A (Director) has filed a Form 3 on Akebia Therapeutics, Inc. |
| 08/02/2016 |
4
| Canute Scott A (Director) has filed a Form 4 on Akebia Therapeutics, Inc. |
| 06/22/2016 |
4/A
| Canute Scott A (Director) has filed a Form 4 on Flexion Therapeutics Inc |
| 06/14/2016 |
4
| Canute Scott A (Director) has filed a Form 4 on PROTEON THERAPEUTICS INC |
| 06/13/2016 |
4
| Canute Scott A (Director) has filed a Form 4 on Flexion Therapeutics Inc |
| 05/18/2016 |
4
| Canute Scott A (Director) has filed a Form 4 on Oncobiologics, Inc.|
Txns:
| Converted 58,500 shares
@ $0
Converted 351 preferred shares
@ $0 |
|
| 07/23/2015 |
4
| Canute Scott A (Director) has filed a Form 4 on PROTEON THERAPEUTICS INC|
Txns:
| Granted 13,333 options to buy
@ $18.25, valued at
$243.3k
|
|
|